Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE